Please enable JavaScript or talk to your local administrator to get JavaScript enabled.


Novel 3D personalized bladder cancer model on demand: A new era for personalized medicine.

Funder: Canadian Institutes of Health Research

Funding period
CAD 186 K
USD 141 K
Funding amount
Bladder cancer (BC) is the 5th most commonly diagnosed cancer in Canada. It is usually manifested as 'superficial' BC. However, 25% of patients progress to a more aggressive and potentially lethal state. Recent studies of BC have revealed several distinct subtypes emphasising the need for an individualized approach. Our group has successfully established a bladder cell removal (decellularization) protocol. These acellular bladders have been seeded with normal bladder cells and grown for up to 1 month showing adequate cell survival. These preliminary results proved to us the feasibility and great potential of engineering bladder tissues. Here we propose to develop a 3D BC model, on demand, using acellular bladder scaffolds as a platform, which will enable us to recreate a BC of a specific patient to test and/or develop drugs. The development of this model will potentially make a step forward on how we currently test anti-cancer drugs. Each 3D BC tissue constructed, will be identical to a specific patient undergoing bladder cancer. This approach will have the potential to simultaneously test multiple anti-cancer drugs before giving the appropriate one to the patient, avoiding sequential unnecessary treatments and reducing side effects which will ultimately improve patient's quality of life. Our model system is a novel approach that will aid in: the mechanistic studies of cell-cell interaction; provide a platform to test and develop new drugs; reduce the number of animals used for experimentation; and, provide a model for preclinical treatment evaluation before deciding on a personalized therapy. At the conclusion of this project we hope to have developed a new tool that will significantly impact the way we currently treat bladder cancer patients.
Similar projects All >
Sorted by: Start Date
Project list item
Roles of epigenetic regulators in bladder cancer progression

University of California - Cancer Research Coordinating Committee to Zhu Wang

USD 74,960
2020 - 2020
Project list item
Quantifying Risk and Resilience (R2) among Patients with Bladder Cancer: A Novel Personalized, Comprehensive Risk Stratification Program

Bladder Cancer Advocacy Network to Sarah Psutka, Jonathan Wright, Daniel Lin, John Gore, Ryan O'Malley, Anne Browning, Florian Fintelmann

USD 50,000
2020 - 2021
Project list item
Bladder cancer chemotherapy potentiation with a multiprong arachidonic acid pathway modulator

National Cancer Institute to PAUL THOMAS HENDERSON

USD 300,000
2019 - 2020



    0601 Biochemistry and Cell Biology


    1112 Oncology and Carcinogenesis

  • RCDC


  • RCDC

    Urologic Diseases




    5.1 Pharmaceuticals

  • Health Research Areas


  • Broad Research Areas

    Basic Science